IGF2BP2 and ovarian carcinoma: The results showed that high expression of ALKBH5 and IGF2BP2 was associated with a poorer prognosis both in OS and PFS analysis in ovarian cancer, which might be due to its high expression in M2 macrophages in ovarian cancer microenvironment (Fig. 4A-B).